Previous 10 | Next 10 |
RALEIGH, N.C., Feb. 11, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, promoted its Chief Financial Officer, Terry Coelho, to Executive Vice Presi...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – February 3, 2021 – With the onset of a world health crisis, our seniors are at a greater risk than they were a decade ago. In addition, the growing senior population has tripled in size ...
Oral Presentation of Data from Phase I Safety Study & Secondary Respiratory Outcomes Comparing BELBUCA ® to Oxycodone on January 16 from 1:10pm – 2:10pm CT RALEIGH, N.C., Jan. 15, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: B...
RALEIGH, N.C., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeff Bailey, Chief Executive Offic...
Today, we revisit a small biopharma concern called BioDelivery Sciences that currently trades at just under $4 a share. The company continues to deliver robust sales growth despite COVID-19 challenges and is becoming increasingly cash flow positive. A full investment analysis on t...
RALEIGH, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey, Chief Executive Officer...
The following slide deck was published by BioDelivery Sciences International, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: BioDelivery Sciences International, Inc. 2020 Q3 - Results - Earnings Call Presentation
Image source: The Motley Fool. Biodelivery Sciences International Inc (NASDAQ: BDSI) Q3 2020 Earnings Call Nov 5, 2020 , 8:30 a.m. ET Operator Continue reading For further details see: Biodelivery Sciences International Inc (BDSI) Q3 2020...
BioDelivery Sciences International, Inc. (BDSI) Q3 2020 Earnings Conference Call November 05, 2020, 08:30 AM ET Company Participants Terry Coelho - CFO Jeff Bailey - CEO Scott Plesha - President and Chief Commercial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Scott...
BioDelivery Sciences ([[BDSI]] +7.8%) Q3 results:Revenues: $39.4M (+30%) in-line with consensus; product sales: $38.79M (+30.9%).Net income: $9.4M vs $0.35M a year ago; income/share: $0.09 vs $0 a year ago; non-GAAP net income: $12.7M vs $3.52M a year ago.Cash flow ops: $14M (+339.3%).EBITDA ...
News, Short Squeeze, Breakout and More Instantly...
BioDelivery Sciences International Inc. Company Name:
BDSI Stock Symbol:
NASDAQ Market:
35 years industry experience including as CEO and founder of public company Stephen Squinto steps down as Chair for new role MILAN, Italy and NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the developm...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...